Supplementary Figure 1 from Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells

Supplementary figure 1 describes how Triamterene requires thymidylate synthase expression to induce selectivity in MMR -deficient cells. Related to Figure 2.